Induction Healthcare Group (LSE:INHC) ROCE % : -16.59% (As of Sep. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Induction Healthcare Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Induction Healthcare Group's annualized ROCE % for the quarter that ended in Sep. 2023 was -16.59%.

Induction Healthcare Group ROCE % Historical Data

The historical data trend for Induction Healthcare Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Induction Healthcare Group ROCE % Chart

Induction Healthcare Group Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

-68.69

-53.18

-27.55

-43.24

Induction Healthcare Group Semi-Annual Data
	Sep18	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
ROCE %	Get a 7-Day Free Trial					-33.19	-14.42	-19.62	-68.37	-16.59

Induction Healthcare Group ROCE % Calculation

Induction Healthcare Group's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	-17.379	/	( ( (55.373 - 6.805)	+	(38.337 - 6.527) )	/ 2 )
	=	-17.379	/	( (48.568	+	31.81)	/ 2 )
	=	-17.379	/	40.189
	=	-43.24 %

Induction Healthcare Group's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Mar. 2023 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Mar. 2023 )		(Q: Sep. 2023 )
	=	-4.832	/	( ( (38.337 - 6.527)	+	(34.342 - 7.9) )	/ 2 )
	=	-4.832	/	( ( 31.81	+	26.442 )	/ 2 )
	=	-4.832	/	29.126
	=	-16.59 %

(1) Note: The EBIT data used here is two times the semi-annual (Sep. 2023) EBIT data.

Induction Healthcare Group (LSE:INHC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Induction Healthcare Group ROCE % Related Terms

Thank you for viewing the detailed overview of Induction Healthcare Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Induction Healthcare Group (LSE:INHC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Induction Healthcare Group PLC (LSE:INHC) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

C/o Pinsent Masons, 30 Crown Place, Earl Street, London, GBR, EC2A 4ES

Website

https://www.inductionhealthcare.com

Induction Healthcare Group PLC is a healthcare technology company focused on streamlining the delivery of care by Healthcare Professionals. The company's mobile application module Induction Switch is an app that provides a directory allowing Healthcare Professionals to find extension numbers, messaging, and administration portals to share and view hospital guidelines. The company's products power remote consultations, capture patient-reported data and empower patients to self-manage their care pathway. Geographically, it operates in the United Kingdom, Europe, the United States and the Rest of the world, out of which the majority of revenue is derived from the United Kingdom.

Induction Healthcare Group (LSE:INHC) Headlines

No Headlines